期刊
JOURNAL OF NANOBIOTECHNOLOGY
卷 19, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12951-021-01140-8
关键词
Phosphomolybdate; Zwitterionic polymer poly (N-vinylpyrrolidone); Plasma protein corona; Mass spectrometry
资金
- National Science Foundation of China [22077079, 81871448]
- Shanghai Municipal Education Commission Project [ZXWF082101]
- Shanghai Municipal Science and Technology Project [2017SHZDZX01, 18430760500]
Phosphomolybdate-based nanoparticles are commonly used in nanomedicine, but protein corona formation upon contact with biofluids can lead to rapid clearance by macrophages. By capping with zwitterionic polymer PVP, the binding sites of proteins on PMo12-based NPs can be effectively reduced, indicating a potential strategy to improve anti-biofouling properties for nanodrug design.
Phosphomolybdate-based nanoparticles (PMo12-based NPs) have been commonly applied in nanomedicine. However, upon contact with biofluids, proteins are quickly adsorbed onto the NPs surface to form a protein corona, which induces the opsonization and facilitates the rapid clearance of the NPs by macrophage uptake. Herein, we introduce a family of structurally homologous PMo12-based NPs (CDS-PMo12 @PVPx(x= 0 similar to 1) NPs) capping diverse content of zwitterionic polymer poly (N-vinylpyrrolidone) (PVP) to regulate the protein corona formation on PMo12-based NPs. The fluorescence quenching data indicate that the introduction of PVP effectively reduces the number of binding sites of proteins on PMo12-based NPs. Molecular docking simulations results show that the contact surface area and binding energy of proteins to CDS-PMo12@PVP1 NPs are smaller than the CDS-PMo12@PVP0 NPs. The liquid chromatography-tandem mass spectrometry (LC-MS/MS) is further applied to analyze and quantify the compositions of the human plasma corona formation on CDS-PMo12 @PVPx(x= 0 - 1) NPs. The number of plasma protein groups adsorption on CDS-PMo12@PVP1 NPs, compared to CDS-PMo12@PVP0 NPs, decreases from 372 to 271. In addition, 76 differentially adsorption proteins are identified between CDS-PMo12@PVP0 and CDS-PMo12 @PVP1 NPs, in which apolipoprotein is up-regulated in CDS-PMo12 @PVP1 NPs. The apolipoprotein adsorption onto the NPs is proposed to have dysoponic activity and enhance the circulation time of NPs. Our findings demonstrate that PVP grafting on PMo12-based NPs is a promising strategy to improve the anti-biofouling property for PMo12-based nanodrug design.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据